Valuation: Remus Pharmaceuticals Limited

Market Cap 7.32B 76.88M 67.21M 61.76M 57.57M 109M 111M 741M 288M 3.6B 289M 282M 12.4B P/E 2024
45.4x
P/E 2025 45.4x
Enterprise Value 7.28B 76.43M 66.81M 61.4M 57.23M 109M 110M 737M 287M 3.58B 287M 281M 12.33B EV / Sales 2024
4.69x
EV / Sales 2025 2.12x
Free-Float
24.75%
Yield 2024
0.09%
Yield 2025 0.07%
1 day+2.86%
1 week-3.31%
Current month-1.52%
1 month+7.82%
3 months+21.82%
6 months-0.20%
Current year+9.29%
1 week 711
Extreme 711
786
1 month 679
Extreme 679
829
Current year 580
Extreme 580
937
1 year 580
Extreme 580
993.95
3 years 378.75
Extreme 378.75
1,417.38
5 years 213.91
Extreme 213.9063
1,417.38
10 years 213.91
Extreme 213.9063
1,417.38
Manager TitleAgeSince
Chief Executive Officer 38 2023-01-15
Director of Finance/CFO - 2023-01-05
Compliance Officer - 2023-01-05
Director TitleAgeSince
Director/Board Member 38 2015-09-20
Chairman 41 2015-09-20
Director/Board Member 38 2015-09-20
Change 5-day change 1-year change 3-year change Capi.($)
+2.86%-3.31%-19.58%+54.06% 93.96M
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+31.35%+24.29% 338B
-0.56%+0.96%+39.86%+36.64% 299B
-0.08%+1.30%+30.37%+44.02% 291B
-1.54%+2.81%-27.56%-39.45% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +2.17%+3.79%+25.94%+57.44% 369.25B
Weighted average by Cap. +2.25%+5.53%+41.78%+83.00%

Financials

2024 2025
Net sales 2.13B 22.36M 19.54M 17.96M 16.74M 31.75M 32.23M 216M 83.82M 1.05B 83.91M 82.11M 3.61B 6.2B 65.15M 56.96M 52.34M 48.79M 92.54M 93.95M 628M 244M 3.05B 245M 239M 10.51B
Net income 215M 2.26M 1.98M 1.82M 1.69M 3.21M 3.26M 21.82M 8.48M 106M 8.49M 8.31M 365M 291M 3.05M 2.67M 2.45M 2.29M 4.34M 4.4M 29.45M 11.45M 143M 11.46M 11.21M 492M
Net Debt -178M -1.87M -1.63M -1.5M -1.4M -2.65M -2.7M -18.03M -7.01M -87.49M -7.02M -6.87M -301M -42.9M -451K -394K -362K -337K -640K -650K -4.35M -1.69M -21.09M -1.69M -1.65M -72.67M
Logo Remus Pharmaceuticals Limited
Remus Pharmaceuticals Limited is an India-based company, which is engaged in marketing and distribution of finished formulations of pharmaceutical drugs. The Company also deals in active pharmaceutical ingredients (APIs). It also provides technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. It offers a range of pharmaceutical formulations and products manufactured on contract manufacturing and on a loan license basis. It deals in drug forms like capsules, cream, eye drops, gel, infusion, inhalation, inhaler, injection, nail lacquer, nasal solution, nasal spray, nebulizer, ointment, ophthalmic, oral gel, oral solution, oral suspension, sachet, suspension and tablet. The Company offers its products in various therapeutic categories, such as oncology, cardiovascular, anti-diabetic, central nervous system (CNS), immunosuppressants, anti-biotic - antibacterial and dermatology.
Employees
-
Date Price Change Volume
26-07-03 ₹767.40 +2.86% 5,400
26-07-02 ₹746.05 +0.24% 2,100
26-07-01 ₹744.30 -4.49% 5,400
26-06-30 ₹779.25 +2.06% 3,100
26-06-29 ₹763.55 -3.80% 4,000
  1. Stock Market
  2. Stocks
  3. REMUS Stock